Italia markets closed

BMY Jan 2026 55.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,25000,0000 (0,00%)
In data: 02:07PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,2500
Aperto2,3400
Denaro2,2500
Lettera2,2800
Prezzo d'esercizio55,00
Scadenza2026-01-16
Min-Max giorno2,2500 - 2,3400
Contratto - Min-MaxN/D
Volume3
Open Interest8,97k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri